These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18498876)

  • 41. Paclitaxel-doxorubicin sequence is more effective in breast cancer cells with heat shock protein 27 overexpression.
    Shi P; Wang MM; Jiang LY; Liu HT; Sun JZ
    Chin Med J (Engl); 2008 Oct; 121(20):1975-9. PubMed ID: 19080259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiation-induced genomic instability in immortalized haemopoietic stem cells.
    McIlrath J; Lorimore SA; Coates PJ; Wright EG
    Int J Radiat Biol; 2003 Jan; 79(1):27-34. PubMed ID: 12556328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
    Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.
    Sakurai T; Kondoh N; Arai M; Hamada J; Yamada T; Kihara-Negishi F; Izawa T; Ohno H; Yamamoto M; Oikawa T
    Cancer Sci; 2007; 98(11):1775-84. PubMed ID: 17727680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
    Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
    Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of human breast adenocarcinoma SK-BR-3 cells resistant to doxorubicin.
    Osmak M; Kapitanović S; Vrhovec I; Beketić-Oresković L; Jernej B; Eljuga D; Skrk J
    Neoplasma; 1997; 44(3):157-62. PubMed ID: 9372856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COX2 expression, angiogenesis, proliferation and survival in Barrett's cancer.
    Möbius C; Stein HJ; Spiess C; Becker I; Feith M; Theisen J; Gais P; Jütting U; Siewert JR
    Eur J Surg Oncol; 2005 Sep; 31(7):755-9. PubMed ID: 15979837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.
    Cano-Soldado P; Molina-Arcas M; Algueró B; Larráyoz I; Lostao MP; Grandas A; Casado FJ; Pastor-Anglada M
    Biochem Pharmacol; 2008 Feb; 75(3):639-48. PubMed ID: 18053967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Vectorisation of doxorubicin in nanospheres and reversion of pleiotropic resistance of tumor cells].
    Treupel L; Poupon MF; Couvreur P; Puisieux F
    C R Acad Sci III; 1991; 313(3):171-4. PubMed ID: 1913255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of cyclooxygenase-2 overexpression on skin carcinogenesis is context dependent.
    Rundhaug JE; Pavone A; Kim E; Fischer SM
    Mol Carcinog; 2007 Dec; 46(12):981-92. PubMed ID: 17583568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance.
    Turton NJ; Judah DJ; Riley J; Davies R; Lipson D; Styles JA; Smith AG; Gant TW
    Oncogene; 2001 Mar; 20(11):1300-6. PubMed ID: 11313874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
    Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
    Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. American Ginseng inhibits induced COX-2 and NFKB activation in breast cancer cells.
    Peralta EA; Murphy LL; Minnis J; Louis S; Dunnington GL
    J Surg Res; 2009 Dec; 157(2):261-7. PubMed ID: 19815237
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolactin upregulates sphingosine kinase-1 expression and activity in the human breast cancer cell line MCF7 and triggers enhanced proliferation and migration.
    Döll F; Pfeilschifter J; Huwiler A
    Endocr Relat Cancer; 2007 Jun; 14(2):325-35. PubMed ID: 17639048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.